K. Slámová et al. / Bioorg. Med. Chem. Lett. 20 (2010) 4263–4265
4265
Table 1
activity towards a range of glycosidases, however, by an estab-
lished HPLC protocol b-N-acetylhexosaminidase from Talaromyces
flavus proved to be able to cleave the intact triazole. This C–N gly-
coside hydrolysis of GlcNAc-triazole 18 is an exceptional feature of
this particular O-glycosidase.
We have furthermore demonstrated the significant binding
affinity of GlcNAc-triazole (18) towards the NK cell activating
receptors (Table 1) CD69 and NKRP-1. This activity could possibly
be considerably enhanced by the construction of a dendrimeric
GlcNAc-display by Cu(I)-catalyzed azide-alkyne cycloaddition.
Values for binding to lymphocyte activating receptors (Àlog IC50
)
NKR-P1A (rat)
CD69 (human)
3.9 ± 0.1
OH
O
HO
HO
5.7 ± 0.1
7.2 ± 0.2
OH
AcNH
(
GlcNAc)
OH
N
N
N
O
HO
HO
5.4 ± 0.2
Acknowledgments
AcNH
(
18)
We thank OChem Graduate School, Aarhus University, Denmark
for financial support (SGH). The Czech Science Foundation (305/09/
H008) and the research concept of the Institute of Microbiology
AV0Z50200510 are acknowledged. K. Krenek is thanked for the
measurement of NK receptor activity.
lysis was found in the absence of enzyme or among the remaining
three b-N-acetylhexosaminidases.
To study the T. flavus catalyzed reaction in detail, a new HPLC
(
HILIC) method was developed to monitor the concentration of
Supplementary data
all reaction mixture components by determining the concentration
of 1,2,3-triazole (Fig. 2, left). Hydrolysis of 18 was found to be lin-
ear in time (Fig. 2, right), but 2000 times slower compared to the
standard substrate 4-nitrophenyl 2-acetamido-2-deoxy-glucopy-
ranoside (pNP-GlcNAc) (2.7 mU vs 5 U, respectively). Despite the
slow reaction rate, the hydrolysis of a C–N bond by an O-glycosi-
dase is a rather unique finding. Upon this result, T. flavus b-N-acet-
ylhexosaminidase was also tested as a potential catalyst for
reaction with another C–N glycoside that is, the thioureido linkage
References and notes
1. Meldal, M.; Tornøe, C. W. Chem. Rev. 2008, 108, 2952.
2.
3.
4.
Debola, S.; Nepogodiev, S. A.; Field, R. A. Org. Biomol. Chem. 2007, 5, 1006.
Dondoni, A. Chem. Asian J. 2007, 2, 700.
van Kasteren, S. I.; Kramer, H. B.; Jensen, H. H.; Campbell, S. J.; Kirkpatrick, J.;
Oldham, N. J.; Anthony, D. C.; Davis, B. G. Nature 2007, 446, 1105.
of 1,2-bis[N-(2-acetamido-2-deoxy-b-
D
-glucopyranosyl)-thiourei-
1
2,22
do]-ethane.
No reaction, however, was detected.
5. Rossi, L. L.; Basu, A. Bioorg. Med. Chem. Lett. 2005, 15, 3596.
6.
Wilkinson, B. L.; Long, H.; Sim, E.; Fairbanks, A. J. Bioorg. Med. Chem. Lett. 2008,
GlcNAc-triazole (18) was also evaluated as a potential ligand
against both rat NKR-P1A and human CD69 receptors by measur-
ing the ability of GlcNAc-triazole 18 to displace a high-affinity
6265.
7.
C-Unsubstituted xylosyl triazoles were made by Cu(I)-catalysis between
glycosyl azide and TMS-acetylene, see: Kuberan, B.; Ethirajan, M.; Victor, X.
V.; Tran, V.; Nguyen, K.; Do, A. ChemBioChem 2008, 9, 198.
1
2,23
receptor ligand.
Triazole 18 showed an approximately 30-
-glucosamine (GlcNAc),
8
9
.
.
Hansen, S. G.; Jensen, H. H. Synlett 2009, 3275.
Tropper, F. D.; Andersson, F. O.; Braun, S.; Roy, R. Synthesis 1992, 618.
times increased affinity over N-acetyl-
D
whereas phenyl or nitrophenyl b-GlcNAc glycosides are usually
associated with approximately a tenfold increase in affinity com-
pared to GlcNAc alone. This significant increase in inhibitory po-
tency of GlcNAc-triazole (18) could be a result of unspecific
10. Korytnyk, W.; Mills, J. A. J. Chem. Soc. 1959, 636.
11. Soli, E. D.; Manoso, A. S.; Patterson, M. C.; DeSong, P.; Favor, D. A.; Hirschmann,
R.; Smith, A. B. J. Org. Chem. 1999, 64, 3171.
1
1
2. See Supplementary data for experimental details.
3. Dedola, S.; Hughes, D. L.; Nepogodiev, S. A.; Rejzek, M.; Field, R. A. Carbohydr.
Res. 2010, 345, 1123.
2
4
augmenting the interaction by the adjacent aromatic moiety.
14. Evaluation of inhibitory potential against glucosidases and galactosidases was
This effect is often observed for interactions between aromatic gly-
cosides and plant as well as animal lectins. From a structural point
of view, this effect has been partially explained on the basis of
chemical stacking interactions of aromatic amino acids often pres-
ent in the carbohydrate binding site of these lectins with the
hydrophobic upper or lower sites of the pyranose carbohydrate
rings, and the adjacent aromatic group. However, very little sys-
tematic studies on these apparently ‘nonspecific’ effects have been
performed so far. The current study is thus among the first to bring
evidence that significant binding effects might be attained varying
the exact chemical structure of the aromatic aglycon ring partici-
pating in these interactions, and thus the fine structure of the elec-
tron clouds involved in these interactions. GlcNAc-triazole (18)
thus constitutes a suitable linkage moiety for the construction of
multivalent neoglycoconjugates for immunological applications.
In conclusion, we have described the first synthesis of 5 differ-
ent glycosyl-1,2,3-triazoles. The products displayed no inhibition
performed according to: Rasmussen, T. S.; Jensen, H. H. Org. Biomol. Chem.
2010, 8, 433.
15. Bröder, W.; Kunz, H. Carbohydr. Res. 1993, 249, 221.
16. Bröder, W.; Kunz, H. Synlett 1990, 252.
1
7. Watt, J. A.; Gannon, C. T.; Loft, K. J.; Dinev, Z.; Williams, S. J. Aust. J. Chem. 2008,
1, 837.
6
1
8. The hydrolysis of glycosyl pyridinium salts have been thoroughly studied, see
Sinnott, M. L.; Withers, S. G. Biochem. J. 1974, 143, 751, and Sinnott, M. L. Chem.
Rev. 1990, 90, 1171.
9. Day, A. G.; Withers, S. G. Biochem. Cell Biol. 1986, 64, 914.
0. Fialová, P.; Carmona, A. T.; Robina, I.; Ettrich, R.; Sedmera, P.; P rˇ ikrylová, V.;
Petrásková-Hušáková, L.; K rˇ en, V. Tetrahedron Lett. 2005, 46, 8715.
1. Bojarová, P.; Petrásková, L.; Ferrandi, E. E.; Monti, D.; Pelantová, H.; Kuzma, M.;
Simerská, P.; K rˇ en, V. Adv. Synth. Catal. 2007, 349, 1514.
1
2
2
2
2
2
2. Bojarová, P.; K rˇ enek, K.; Wetjen, K.; Adamiak, K.; Pelantova, H.; Bezouška, K.;
Elling, L.; K rˇ en, V. Glycobiology 2009, 19, 509.
3. Bezouška, K.; Vlahas, G.; Horváth, O.; Jinochová, G.; Fišerová, A.; Giorda, R.;
Chambers, W. H.; Feizi, T.; Pospíšil, M. J. Biol. Chem. 1994, 269, 16945.
4. Krist, P.; Herkommerová-Rajnochová, E.; Rauvolfová, J.; Seme nˇ uk, T.;
Vavrušková, P.; Pavlí cˇ ek, J.; Bezouška, K.; Petruš, L.; K rˇ en, V. Biochem. Biophys.
Res. Commun. 2001, 287, 11.